This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Marshall D. Lindheimer, MD
Departments of Medicine and Obstetrics and Gynecology University of Chicago 5841 S Maryland Ave Chicago, IL 60637

Arch Neurol. 1989;46(11):1164-1165.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—We wish to commend the ARCHIVES^1-3 for focusing on certain controversies regarding the use of magnesium sulfate for preeclampsia, or frank eclampsia, but have misgivings on the manner in which the problem was presented. Most importantly, the following facts should have been noted. In the United States more than 95% of the women with preeclampsia or eclampsia are managed by obstetricians, including those who are trained and certified in the subspecialty of fetal-maternal medicine. Neurologists and internists are mainly consulted for "atypical" cases. Thus, it is the American College of Obstetricians and Gynecologists and the various certifying boards that set standards of care for the profession, and magnesium sulfate is currently standard treatment when a women presents with severe preeclampsia or eclampsia.⁴ Said otherwise, regardless of what appropriate future research may reveal, failure to treat with magnesium sulfate in 1988 and 1989 might conceivably expose your . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?